Global Custom Monoclonal Antibody Market expected to reach XX Million by 2025

2018-03-12 17:04:23

According to a new report published by Reports Monitor titled, “Custom Monoclonal Antibody Market by type, application, End-user: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the custom monoclonal antibody Market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025. North America accounts for highest share of the market and is expected to grow continuously throughout the forecast period.

Monoclonal antibodies are class of antibodies that are obtained from single parent cell and are identical unique offspring’s of a hybridoma. Monoclonal antibodies have monovalent affinity, meaning that they can determine identical epitope which might be present on different surfaces of various antigens. Custom monoclonal antibodies are produced in accordance to predefined protein antigen or particular peptide to which they have increased activity, affinity and specificity. Being very precise in nature custom monoclonal antibodies has been proven as progressive development in the field of healthcare where it can be used in cancer treatment to defeat the tumor or malignancy of the cells.

Get a Sample PDF Report @

Growing funding of government in research and development and technological advancement are key forces mainly driving the global market of custom antibody. According to report published in 2016 in R&D magazine Asia holds over 42% of the total R&D investment and China’s investment is rising 10% per year whereas, global expenditure of custom monoclonal antibodies was estimated to be around USD 2.06 trillion. In addition commonly occurring infections and immunological diseases, predominance of chronic disorders and sedentary lifestyle is fuelling the growth of the market. Unlike chemotherapy custom monoclonal antibody does not cause any damage to healthy cells instead target only diseased cells providing opportunity to set up its own market. 

Key Findings and scope
• The global custom monoclonal antibody service is estimated to reach XX Million for the forecast period of 2017 to 2025 at a CAGR of XX%
• Considering type, rat custom monoclonal antibody market is anticipated to hold the major share of the market in terms of volume and value and to grow at CAGR of XX% followed by rabbit custom monoclonal antibody
• On the basis of application, cancer treatment application of monoclonal antibody is expected to reach XX million by 2025 growing at a CAGR of XX%.
• As per estimate provided by American Cancer Society in 2017, approximately 1.6 million new cases are expected to be diagnosed in United States. North America is predicted to be fastest growing region geographically and expected to reach XX million by 2025 growing at a CAGR of XX%. 

Major Key players included in the report are: Thermo Fischer, Genscript, Abnova Corporation, Creative Biolabs, Abcam Plc, Proman biotechnologies, Envigo, F. Hoffmann-La Roche, Johnson & Johnson0, BMS, and AbbVie

About Us:

We at Garner provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us:

Mr. Kevin Thomas


+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]

Related Press Releases